文献速递姑息放疗与转移瘤放疗物理与技术

脊柱转移瘤再程放疗:三 Fraction SBRT 的疗效与安全性

Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases.
PubMed 文献 · Pract Radiat Oncol · 2026-03-03

该研究基于单中心数据库,分析了83例患者共87个脊柱病灶在接受既往重叠放疗后行三Fraction脊柱立体定向体部放疗(SBRT)的结局。中位随访14.2个月,2年局部失败率为15%,2年局部控制率达85%,放射性脊髓炎发生率为1.3%,椎体压缩骨折发生率为5.5%。

要点

  • 三Fraction脊柱SBRT再程放疗的2年局部控制率为85%。
  • 放射性脊髓炎发生率1.3%,椎体压缩骨折发生率5.5%。
  • PTV最小剂量较低和胃肠道病理类型与局部失败风险升高相关。

核心结论

  • 三Fraction脊柱SBRT再程放疗似乎是安全的,并与85%的2年局部控制率相关。

研究设计与样本

  • 单中心回顾性数据库分析,纳入2014年至2023年间83例患者共87个脊柱病灶,均接受既往重叠放疗后行三Fraction脊柱SBRT。
  • 主要结局为基于磁共振成像定义的照射病灶局部失败(LF),同时评估椎体压缩骨折和放射性脊髓炎等毒性。

主要发现

  • 中位随访14.2个月(IQR,6-29.4),中位总生存期为20.5个月(95% CI,16.5-29.9)。
  • 1年和2年局部失败率分别为8.4%(95% CI,3.7%-16%)和15%(95% CI,8.1%-24%)。
  • 放射性脊髓炎1例(1.3%),椎体压缩骨折5例(5.5%)。

关键数值与推荐

  • 大多数病灶(78个,90%)接受27 Gy分3次照射。
  • 大多数病灶(59%)既往接受过常规分割放疗,最常见病理类型为前列腺癌(15例,17%)。

临床怎么用

  • 对于既往接受过重叠放疗的脊柱转移瘤患者,三Fraction脊柱SBRT再程放疗可作为安全的选择,2年局部控制率达85%。
  • PTV最小剂量较低和胃肠道病理类型可能提示局部失败风险升高,需在计划制定和随访中关注。

局限性

  • 单中心回顾性研究,样本量有限(83例患者、87个病灶)。
  • 局部失败风险因素基于单变量分析,未报告多变量分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to characterize outcomes from a large institutional database of patients treated with 3-fraction spine stereotactic body radiation therapy (SBRT) after prior overlapping radiation therapy. METHODS AND MATERIALS: The primary outcome of interest was local failure (LF) in the treated lesion, defined based on magnetic resonance imaging. We also characterized toxicities such as vertebral compression fracture and radiation myelitis. RESULTS: There were 83 patients treated to 87 spinal lesions between 2014 and 2023. Median follow-up was 14.2 (IQR, 6-29.4) months, and median overall survival was 20.5 (95% CI, 16.5-29.9) months. Most lesions were treated with 27 Gy in 3 fractions (n = 78; 90%). Most lesions had been treated with prior conventionally fractionated radiation therapy (59%), and the most common histology was prostate cancer (n = 15; 17%). The 1- and 2-year LF rate was 8.4% (95% CI, 3.7%-16%) and 15% (95% CI, 8.1%-24%), respectively. On univariable analysis, lower minimum dose to the planning target volume (hazard ratio, 0.85, 95% CI, 0.74-0.99, P = .03) and colorectal, cholangio-, or hepatocellular carcinoma histology (hazard ratio 5.6, 95% CI, 1.11-28.4, P = .037) were associated with risk of LF. There was 1 case of radiation myelitis (1.3%) and 5 cases (5.5%) of vertebral compression fracture. CONCLUSION: Reirradiation with spine SBRT in 3 fractions appears safe and is associated with a 2-year local control rate of 85%. Lower planning target volume, lower minimum dose, and gastrointestinal histology were associated with increased risk of LF. Further work is needed to identify the optimal dose-fractionation regimen for reirradiation with spine SBRT.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jackson CB, Zhang L, Haseltine J, et al. Reirradiation With Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases. Pract Radiat Oncol. 2026. PMID: 41786078. doi:10.1016/j.prro.2026.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。